BE529076A - - Google Patents
Info
- Publication number
- BE529076A BE529076A BE529076DA BE529076A BE 529076 A BE529076 A BE 529076A BE 529076D A BE529076D A BE 529076DA BE 529076 A BE529076 A BE 529076A
- Authority
- BE
- Belgium
- Prior art keywords
- beta
- heated
- reaction
- general formula
- orthoester
- Prior art date
Links
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 20
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 10
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 10
- 150000002905 orthoesters Chemical class 0.000 claims description 10
- 238000010992 reflux Methods 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 4
- 150000008360 acrylonitriles Chemical class 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000012295 chemical reaction liquid Substances 0.000 description 12
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- 235000019441 ethanol Nutrition 0.000 description 9
- SUSQOBVLVYHIEX-UHFFFAOYSA-N phenylacetonitrile Chemical compound N#CCC1=CC=CC=C1 SUSQOBVLVYHIEX-UHFFFAOYSA-N 0.000 description 6
- FGWYWKIOMUZSQF-UHFFFAOYSA-N 1,1,1-triethoxypropane Chemical compound CCOC(CC)(OCC)OCC FGWYWKIOMUZSQF-UHFFFAOYSA-N 0.000 description 5
- FKRCODPIKNYEAC-UHFFFAOYSA-N propionic acid ethyl ester Natural products CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 5
- 238000004508 fractional distillation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 3
- 150000003230 pyrimidines Chemical class 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- OLGYAOFWACOZCU-UHFFFAOYSA-N 3-oxopent-4-enenitrile Chemical compound C=CC(=O)CC#N OLGYAOFWACOZCU-UHFFFAOYSA-N 0.000 description 2
- IVYMIRMKXZAHRV-UHFFFAOYSA-N 4-chlorophenylacetonitrile Chemical compound ClC1=CC=C(CC#N)C=C1 IVYMIRMKXZAHRV-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- NDQXKKFRNOPRDW-UHFFFAOYSA-N 1,1,1-triethoxyethane Chemical compound CCOC(C)(OCC)OCC NDQXKKFRNOPRDW-UHFFFAOYSA-N 0.000 description 1
- VOVBMIURXODOAY-UHFFFAOYSA-N 1-(2-methylpropoxy)propane-1,1-diol Chemical compound CCC(O)(O)OCC(C)C VOVBMIURXODOAY-UHFFFAOYSA-N 0.000 description 1
- LBKIRBXELMWQRC-UHFFFAOYSA-N 1-methoxypropane-1,1-diol Chemical compound CCC(O)(O)OC LBKIRBXELMWQRC-UHFFFAOYSA-N 0.000 description 1
- MRDUURPIPLIGQX-UHFFFAOYSA-N 2-(2-chlorophenyl)acetonitrile Chemical compound ClC1=CC=CC=C1CC#N MRDUURPIPLIGQX-UHFFFAOYSA-N 0.000 description 1
- NDZJWZZUVLHFBE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-(2-methylpropoxy)pent-2-enenitrile Chemical compound CC(C)COC(CC)=C(C#N)C1=CC=C(Cl)C=C1 NDZJWZZUVLHFBE-UHFFFAOYSA-N 0.000 description 1
- UNUCYCXGZOBLDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-methoxypent-2-enenitrile Chemical compound CCC(OC)=C(C#N)C1=CC=C(Cl)C=C1 UNUCYCXGZOBLDE-UHFFFAOYSA-N 0.000 description 1
- IPBZEJZUAZXNOS-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-oxobutanenitrile Chemical compound CC(=O)C(C#N)C1=CC=C(Cl)C=C1 IPBZEJZUAZXNOS-UHFFFAOYSA-N 0.000 description 1
- GWPXIALXVWOQNJ-UHFFFAOYSA-N 2-(4-chlorophenyl)-4-ethylpyrimidine Chemical compound CCC1=CC=NC(C=2C=CC(Cl)=CC=2)=N1 GWPXIALXVWOQNJ-UHFFFAOYSA-N 0.000 description 1
- NRGGMCIBEHEAIL-UHFFFAOYSA-N 2-ethylpyridine Chemical compound CCC1=CC=CC=N1 NRGGMCIBEHEAIL-UHFFFAOYSA-N 0.000 description 1
- VCPXZIUQCXEVCU-UHFFFAOYSA-N 4-ethylpyrimidine Chemical compound CCC1=CC=NC=N1 VCPXZIUQCXEVCU-UHFFFAOYSA-N 0.000 description 1
- QSQICMKUCZOGCO-UHFFFAOYSA-N 5-(4-chlorophenyl)-4-ethylpyrimidine Chemical compound CCC1=NC=NC=C1C1=CC=C(Cl)C=C1 QSQICMKUCZOGCO-UHFFFAOYSA-N 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 chlorophenyl-beta-ethoxy-beta-methylacrylonitrile Chemical compound 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
Publication Number | Publication Date |
---|---|
BE529076A true BE529076A (d) |
Family
ID=162182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BE529076D BE529076A (d) |
Country Status (1)
Country | Link |
---|---|
BE (1) | BE529076A (d) |
-
0
- BE BE529076D patent/BE529076A/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0433135B1 (fr) | Procédé de préparation de (meth)acrylate d'alkylimidazolidone | |
BE529076A (d) | ||
CH320309A (fr) | Procédé de préparation d'acrylonitriles | |
FR2615853A1 (fr) | Nouveau procede pour la preparation de derives de la piperazine pharmacologiquement actifs, derives et nouveaux intermediaires obtenus | |
EP0354078B1 (fr) | Nouveaux dérivés du benzocycloheptène, leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
WO1999011602A1 (fr) | Procede de preparation de composes de type arylaminoalkylidenemalonates | |
BE504901A (d) | ||
BE500594A (d) | ||
FR2473512A1 (fr) | Nouveaux 2-aminomethyl-6-halogeno-phenols, leur preparation et leur application comme medicaments | |
FR2738825A1 (fr) | Procede de purification d'un 1,3-bis(3-aminopropyl)-1,1, 3,3-tetraorgano-disiloxane | |
BE520993A (d) | ||
BE568394A (d) | ||
BE536145A (d) | ||
BE567520A (d) | ||
CH320138A (fr) | Procédé de fabrication d'esters présentant une activité thérapeutique de thréo-1-p-nitrophényl-2-dichloroacétamido-propane-1,3-diol | |
BE569076A (d) | ||
BE523490A (d) | ||
BE830870A (fr) | Derives de benzisoxazole | |
BE631729A (d) | ||
EP0950052A1 (fr) | Procede pour la preparation d'un derive de tetrahydropyridine | |
BE519639A (d) | ||
BE632152A (d) | ||
BE564597A (d) | ||
BE887039A (fr) | Nouveaux 2-aminomethyl-6-halogeno-phenols, leur preparation et leur application comme medicaments | |
BE441883A (d) |